We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

274 hedge funds and large institutions have $3.94B invested in Abiomed Inc in 2016 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 109 increasing their positions, 83 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

423% more call options, than puts

Call options by funds: $51.4M | Put options by funds: $9.84M

85% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 33

31% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 83

10% more funds holding

Funds holding: 249274 (+25)

10% more capital invested

Capital invested by funds: $3.58B → $3.94B (+$358M)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

Holders
274
Holders Change
+25
Holders Change %
+10.04%
% of All Funds
7.3%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.21%
New
61
Increased
109
Reduced
83
Closed
33
Calls
$51.4M
Puts
$9.84M
Net Calls
+$41.6M
Net Calls Change
+$41M
Name Holding Trade Value Shares
Change
Change in
Stake
GIM
26
Granahan Investment Management
Massachusetts
$30.6M +$2.82M +33,400 +12%
Mitsubishi UFJ Trust & Banking
27
Mitsubishi UFJ Trust & Banking
Japan
$28.6M +$6.95M +82,280 +37%
Renaissance Technologies
28
Renaissance Technologies
New York
$27.2M +$14.6M +173,400 +153%
ACM
29
Apex Capital Management
Ohio
$26.4M +$3.76M +44,570 +19%
SIMG
30
Stephens Investment Management Group
Texas
$25M +$1.99M +23,550 +10%
Janus Henderson Group
31
Janus Henderson Group
United Kingdom
$24.7M -$632K -7,492 -3%
NFA
32
Nationwide Fund Advisors
Ohio
$22.8M +$2.37M +28,018 +19%
BIM
33
BlackRock Investment Management
Delaware
$22.5M +$6.85M +81,150 +52%
RFS
34
Rockefeller Financial Services
New York
$22.2M -$483K -5,719 -2%
Wellington Management Group
35
Wellington Management Group
Massachusetts
$22M -$469K -5,553 -2%
Ameriprise
36
Ameriprise
Minnesota
$21.2M -$47.5K -563 -0.3%
PC
37
Polar Capital
United Kingdom
$20.7M +$18.4M +218,000 New
TA
38
Teachers Advisors
New York
$20.5M -$1.08M -12,752 -6%
FAM
39
Fred Alger Management
New York
$20.4M -$638K -7,556 -3%
GC
40
Guggenheim Capital
Illinois
$20M +$12.7M +150,099 +247%
Wells Fargo
41
Wells Fargo
California
$19.6M +$2.24M +26,570 +15%
William Blair & Company
42
William Blair & Company
Illinois
$19.5M -$1.7M -20,115 -9%
Invesco
43
Invesco
Georgia
$19.1M -$6.1M -72,242 -26%
CCM
44
Cupps Capital Management
Illinois
$18.9M -$6.6M -78,177 -28%
CAM
45
Cortina Asset Management
Wisconsin
$18.8M -$6.16M -72,957 -27%
SEI Investments
46
SEI Investments
Pennsylvania
$18.5M -$2.64M -31,265 -14%
O
47
OppenheimerFunds
New York
$18.2M +$3.67M +43,434 +29%
Public Employees Retirement Association of Colorado
48
Public Employees Retirement Association of Colorado
Colorado
$17.9M -$88.9K -1,053 -0.6%
TCIM
49
TIAA CREF Investment Management
New York
$17M +$666K +7,886 +5%
Bank of America
50
Bank of America
North Carolina
$16.4M +$1.85M +21,923 +15%

ABMD Hedge Fund Activity: Q1 2016 in Review

274 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2016, worth a combined $3.94B — up 10% from $3.58B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new ABMD positions and 33 closed out — a net gain of 28 holders — while 109 added to existing stakes and 83 trimmed.

The largest buyer was 1832 Asset Management, opening a new position worth an estimated $67.6M. The largest seller was Essex Woodlands Management, cutting an estimated $59.1M.

  • 274 institutional investors held Abiomed Inc (ABMD) as of Q1 2016, up from 249 in Q4 2015.
  • Funds reported $3.94B of Abiomed Inc stock for Q1 2016, up 10% quarter-over-quarter.
  • 61 funds opened new Abiomed Inc positions in Q1 2016 and 33 closed out, a net change of +28 holders.
  • The largest Abiomed Inc buyer in Q1 2016 was 1832 Asset Management, an estimated $67.6M added.
  • The largest Abiomed Inc seller in Q1 2016 was Essex Woodlands Management, an estimated $59.1M sold.

Based on aggregated 13F filings for Q1 2016.